Sjögren’s Syndrome

touchIMMUNOLOGY spoke with editorial board member Alessia Alunno (University of L’Aquila, Italy) to discuss her highlights from the European Alliance of Associations for Rheumatology (EULAR) annual meeting in the field of Sjögren’s syndrome, and summarize the main take-home messages from her presentation. The abstract ‘COVID-19 severity and vaccine breakthrough infections in Sjögren’s syndrome: results from the […]

It was great to talk with Professor Xavier Mariette (Université Paris-Saclay and Hôpital Bicêtre, Paris, France) around the current challenges and potential advances in treating Sjögren’s syndrome. Questions Why have so many clinical trials failed in primary Sjögren’s syndrome? (0:15) What are the hot topics and latest research you are looking forward to exploring in Sjögren’s syndrome […]

It was a delight to catch up with Professor Xavier Mariette (Université Paris-Saclay and Hôpital Bicêtre, Paris, France) around the phase 2 study investigating subcutaneous belimumab and intravenous rituximab in primary Sjögren’s syndrome. The abstract ‘SAFETY AND EFFICACY OF SUBCUTANEOUS BELIMUMAB AND INTRAVENOUS RITUXIMAB COMBINATION IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME: A PHASE 2, RANDOMISED, PLACEBO-CONTROLLED […]